Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received only first dose of Twinrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 46-year-old male patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (patient received the first dose of Twinrix on October 9, 2017 with batch no. L5SH5). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: received only first dose of Twinrix). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 21-JAN-2025 Other HCP reported that a 46 years old male patient received the first dose of Twinrix on October 9th, 2017. Reporter asked if the patient need to start over the series. Till the time of reporting patient did not receive 2nd dose of Twinrix which led to incomplete course of vaccination.